Arrowhead Research reported $-29924000 in Net Income for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Agios Pharmaceuticals AGIO:US $ -86.22M 1960.54M
Alnylam Pharmaceuticals ALNY:US $ -189.56M 10.73M
Anika Therapeutics ANIK:US $ 6.53M 3.69M
Arena Pharmaceuticals ARNA:US $ -146.1M 27.68M
Arrowhead Research ARWR:US $ -29924000 3.11M
Bluebird Bio BLUE:US $ -241.7M 35.89M
Cerulean Pharma CERU:US $ -9.16M 1.84M
Dicerna Pharmaceuticals DRNA:US $ -40.82M 10.85M
Heron Therapeutics HRTX:US $ -61.02M 8.4M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
IONIS PHARMACEUT IONS:US $ -80.88M 8.99M
Ligand Pharmaceuticals LGND:US $ 30.72M 12.62M
Merk MRK:US $ 1545M 1634M
Mirati Therapeutics MRTX:US $ -166.43M 30.75M
Moderna Inc MRNA:US 2.78B 1.56B
Nektar Therapeutics NKTR:US $ -125.52M 2.55M
Novartis NOVN:VX SF 2896M 837M
Opko Health OPK:US $ -16.19M 47.26M
Sarepta Therapeutics SRPT:US $ -81.4M 85.84M
Spectrum Pharmaceuticals SPPI:US $ -50.13M 14.44M
Tg Therapeutics TGTX:US $ -78.5M 12.13M
Ultragenyx Pharmaceutical RARE:US $ -122.43M 13.71M
Vertex Pharmaceuticals VRTX:US $ 66.92M 586.21M
Xencor XNCR:US $ 52.25M 54.74M
YTE INCY:US $ 149.46M 95.92M